Zhu Wei, Zhao Tianhao, Wang Han, Liu Guangli, Bian Yixin, Wang Qi, Xia Wei, Cai Siyi, Weng Xisheng
State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Department of Orthopedics, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Bioengineering (Basel). 2025 May 31;12(6):599. doi: 10.3390/bioengineering12060599.
(1) Background: Osteonecrosis of the femoral head (ONFH), caused by insufficient blood supply, leads to bone tissue death. Current treatments lack effective bone regeneration materials to reverse disease progression. This study introduces an injectable and self-setting 3D porous bioceramic scaffold (Mg@Ca), combining MgO + SiO mixtures with α-hemihydrate calcium sulfate, designed to promote bone repair through in situ pore formation and osteoinduction. (2) Methods: In vitro experiments evaluated human bone marrow mesenchymal stem cell (h-BMSC) proliferation, differentiation, and osteogenic marker expression in Mg@Ca medium. Transcriptome sequencing identified bone development-related pathways. In vivo efficacy was assessed in a rabbit model of ONFH to evaluate bone repair. (3) Results: The Mg@Ca scaffold demonstrated excellent biocompatibility and supported h-BMSC proliferation and differentiation, with significant up-regulation of and . Transcriptome analysis revealed activation of the PI3K-Akt signaling pathway, critical for osteogenesis. In vivo results confirmed enhanced trabecular density and bone volume compared to controls, indicating effective bone repair and regeneration. (4) Conclusions: The Mg@Ca scaffold offers a promising therapeutic approach for ONFH, providing a minimally invasive solution for bone defect repair while stimulating natural bone regeneration. Its injectable and self-setting properties ensure precise filling of bone defects, making it suitable for clinical applications.
(1) 背景:股骨头缺血性坏死(ONFH)由血液供应不足引起,导致骨组织死亡。目前的治疗方法缺乏有效的骨再生材料来逆转疾病进展。本研究引入了一种可注射且能自固化的三维多孔生物陶瓷支架(Mg@Ca),它将氧化镁+二氧化硅混合物与α-半水硫酸钙相结合,旨在通过原位成孔和骨诱导促进骨修复。(2) 方法:体外实验评估了人骨髓间充质干细胞(h-BMSC)在Mg@Ca培养基中的增殖、分化以及成骨标志物表达。转录组测序确定了与骨发育相关的途径。在ONFH兔模型中评估体内疗效以评价骨修复情况。(3) 结果:Mg@Ca支架表现出优异的生物相容性,支持h-BMSC的增殖和分化,以及[具体基因名称1]和[具体基因名称2]的显著上调。转录组分析揭示了PI3K-Akt信号通路的激活,这对成骨至关重要。体内结果证实与对照组相比,骨小梁密度和骨体积增加,表明有效的骨修复和再生。(4) 结论:Mg@Ca支架为ONFH提供了一种有前景的治疗方法,为骨缺损修复提供了微创解决方案,同时刺激自然骨再生。其可注射和自固化特性确保了骨缺损的精确填充,使其适用于临床应用。